//
Caner Saygin
Christopher N Hahn
Rakchha Chhetri
Saar Gill
Hany Elmariah
Chetasi Talati
Emma Nunley
Guimin Gao
Aelin Kim
Michael R. Bishop
Satyajit Kosuri
Soma Das
Deepak Singhal
Parvathy Venugopal
Claire Homan
Anna L. Brown
Hamish S Scott
Devendra Hiwase
Lucy A. Godley
Adelaide Medical School, University of Adelaide, Adelaide, Australia
University of Chicago Department of Informatics and Biostatistics, Chicago, IL
Moffitt Cancer Center, Tampa, FL
Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
Section of Hematology/Oncology, The University of Chicago, Chicago, IL
The David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL
Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia
Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
Department of Human Genetics, The University of Chicago, Chicago, IL
Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia
Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
Department of Haematology, Royal Adelaide Hospital, Adelaide, Australia
Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, Australia
University of Chicago Section of Hematology/Oncology, Chicago, IL
Australia
United States
N/A
Oncology (ONC)
Autoimmune (AI)
Graft-versus-host disease
Solid malignancies
checkpoint kinase 2
Apparent diffusion coefficient
Cyclophosphamide
Cyclophosphamide Injection
N/A
Multinational
Cohort
NA
N/A
N/A
N/A